(Q41247823)

28 September 2017

Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines (English)

1 reference

28 September 2017

1 reference

H Jinno

1

1 reference

28 September 2017

M Ueda

2

1 reference

28 September 2017

K Enomoto

3

1 reference

28 September 2017

T Ikeda

4

1 reference

28 September 2017

P Kyriakos

5

1 reference

28 September 2017

M Kitajima

6

1 reference

28 September 2017

1 January 1996

1 reference

28 September 2017

1 reference

28 September 2017

26

1 reference

28 September 2017

501-507

1 reference

28 September 2017

7

1 reference

Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor

28 September 2017

1 reference

12 December 2020

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

12 December 2020

Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line

1 reference

12 December 2020

p185neu expression in human lung adenocarcinomas predicts shortened survival

1 reference

12 December 2020

The anthracycline antineoplastic drugs

1 reference

12 December 2020

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

12 December 2020

Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Targeted killing of squamous carcinoma cells by a monoclonal antibody-peplomycin conjugate which recognizes the EGF receptor

1 reference

12 December 2020

Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins

1 reference

12 December 2020

Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses

1 reference

12 December 2020

The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities

1 reference

12 December 2020

C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells

1 reference

12 December 2020

Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody

1 reference

12 December 2020

Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer

1 reference

12 December 2020

1 reference

12 December 2020

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

1 reference

12 December 2020

Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures

1 reference

12 December 2020

Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing

1 reference

12 December 2020

In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

1 reference

12 December 2020

Doxorubicin: monoclonal antibody conjugate for therapy of human cervical carcinoma

1 reference

12 December 2020

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker

1 reference

12 December 2020

The effect of anti-α-fetoprotein-adriamycin conjugate on a human hepatoma

1 reference

12 December 2020

Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer

1 reference

12 December 2020

Identification of heregulin, a specific activator of p185erbB2

1 reference

12 December 2020

Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice

1 reference

12 December 2020

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00311556

1 reference

28 September 2017

1 reference